Dentists in Crandon, WI Accepting Medicare
3 Dentists found. Showing 1 - 3
 Dr. Eve Louise Van Harpen, DDS Dentist Medicare: Medicare Enrolled Practice Location: 8201 Mish Ko Swen Dr, Crandon, WI 54520 Phone: 715-478-4338 |
 Jeffrey D Nielsen, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 3144 Van Zile Rd., Crandon, WI 54520 Phone: 715-478-5180 |
Mr. Kirk R Ritchie, DDS Dentist Medicare: Medicare Enrolled Practice Location: 5409 Everybodys Road, Forest County Potawatomi Health & Wellness Center, Crandon, WI 54520 Phone: 715-478-4300 Fax: 715-478-4490 |
News Archive
H70 study provides data on cognitive symptoms that predict dementia
Today´s 70-year-olds do far better in intelligence tests than their predecessors. It has also become more difficult to detect dementia in its early stages, though forgetfulness is still an early symptom, reveals new research from the University of Gothenburg, Sweden, based on the H70 study.
Spending more time outdoors may prevent short-sightedness in children
Adding an extra 40 minutes of outdoor activity to children's usual time outdoors reduced the incidence of myopia over a three year period, providing the first indicator that myopia may actually be preventable.
Prostate cancer: Surgery in county hospitals, radiation or hormone therapy in private facilities
Researchers at Moores Cancer Center at the University of California, San Diego and colleagues have found that prostate cancer treatments varied significantly between county hospitals and private providers. Patients treated in county hospitals are more likely to undergo surgery while patients treated in private facilities tend to receive radiation or hormone therapy. These findings were published online by the journal Cancer on January 25.
Mycovia initiates two Phase 3 clinical trials to evaluate VT-1161 in patients with RVVC
Mycovia Pharmaceuticals, making its official debut as a company developing therapies in women's health and dermatology, today announced the initiation of two Phase 3 clinical trials called VIOLET to evaluate the safety and efficacy of its lead candidate, VT-1161, in patients with recurrent vulvovaginal candidiasis
› Verified 6 days ago